Aron Skaftason

455 total citations
7 papers, 84 citations indexed

About

Aron Skaftason is a scholar working on Molecular Biology, Hematology and Cancer Research. According to data from OpenAlex, Aron Skaftason has authored 7 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Hematology and 4 papers in Cancer Research. Recurrent topics in Aron Skaftason's work include Acute Myeloid Leukemia Research (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lymphoma Diagnosis and Treatment (2 papers). Aron Skaftason is often cited by papers focused on Acute Myeloid Leukemia Research (4 papers), Cancer Genomics and Diagnostics (3 papers) and Lymphoma Diagnosis and Treatment (2 papers). Aron Skaftason collaborates with scholars based in Sweden, Denmark and Finland. Aron Skaftason's co-authors include Lucia Cavelier, Katja Pokrovskaja Tamm, Josefine Palle, Martin Höglund, Morten Krogh Herlin, Markus Mayrhofer, Jonas Abrahamsson, Jan Komorowski, Bernward Zeller and Monica Cheng Munthe‐Kaas and has published in prestigious journals such as Scientific Reports, Leukemia and Frontiers in Oncology.

In The Last Decade

Aron Skaftason

7 papers receiving 83 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aron Skaftason Sweden	5	50	44	24	12	10	7	84
Kathleen Stabla Germany	5	35 0.7×	30 0.7×	14 0.6×	15 1.3×	13 1.3×	6	76
Matthieu Duchmann France	4	61 1.2×	46 1.0×	18 0.8×	8 0.7×	9 0.9×	11	92
Cecilia A. Castellano United States	2	23 0.5×	74 1.7×	14 0.6×	6 0.5×	6 0.6×	4	89
Laurène Fenwarth France	6	56 1.1×	39 0.9×	12 0.5×	9 0.8×	3 0.3×	19	92
Konstanze Doehner Germany	4	41 0.8×	68 1.5×	12 0.5×	14 1.2×	6 0.6×	14	101
Kazuki Terada Japan	4	76 1.5×	55 1.3×	18 0.8×	5 0.4×	6 0.6×	8	101
Valentina Robustelli Italy	6	37 0.7×	63 1.4×	13 0.5×	11 0.9×	7 0.7×	13	103
Kalyan Nadiminti United States	6	68 1.4×	65 1.5×	9 0.4×	19 1.6×	7 0.7×	24	115
Claudia Sargas Spain	5	82 1.6×	94 2.1×	19 0.8×	12 1.0×	7 0.7×	10	129
Gunilla Walldin Sweden	4	46 0.9×	26 0.6×	16 0.7×	31 2.6×	11 1.1×	12	86

Countries citing papers authored by Aron Skaftason

Since Specialization

Citations

This map shows the geographic impact of Aron Skaftason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aron Skaftason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aron Skaftason more than expected).

Fields of papers citing papers by Aron Skaftason

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aron Skaftason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aron Skaftason. The network helps show where Aron Skaftason may publish in the future.

Co-authorship network of co-authors of Aron Skaftason

This figure shows the co-authorship network connecting the top 25 collaborators of Aron Skaftason. A scholar is included among the top collaborators of Aron Skaftason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aron Skaftason. Aron Skaftason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

7 of 7 papers shown

1.

Diamanti, Klev, Louella Vasquez, Paul Theodor Pyl, et al.. (2025). Combinatorial DNMTs and EZH2 inhibition reprograms the H3K27me3 and DNAme-mediated onco-epigenome to suppress multiple myeloma proliferation. Scientific Reports. 15(1). 31568–31568. 2 indexed citations

2.

Rezayee, Fatemah, Jesper Eisfeldt, Aron Skaftason, et al.. (2023). Feasibility to use whole-genome sequencing as a sole diagnostic method to detect genomic aberrations in pediatric B-cell acute lymphoblastic leukemia. Frontiers in Oncology. 13. 1217712–1217712. 11 indexed citations

3.

Haider, Z., Tove Wästerlid, Leily Rabbani, et al.. (2023). Whole-genome informed circulating tumor DNA analysis by multiplex digital PCR for disease monitoring in B-cell lymphomas: a proof-of-concept study. Frontiers in Oncology. 13. 1176698–1176698. 5 indexed citations

4.

Vesterlund, Mattias, Husen M. Umer, Saeed Eshtad, et al.. (2022). Proteogenomic analysis of acute myeloid leukemia associates relapsed disease with reprogrammed energy metabolism both in adults and children. Leukemia. 37(3). 550–559. 14 indexed citations

5.

Sun, Jitong, Aron Skaftason, Markus Mayrhofer, et al.. (2021). Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression. Blood Advances. 6(1). 152–164. 19 indexed citations

6.

Mayrhofer, Markus, Aron Skaftason, Jitong Sun, et al.. (2021). Genomic characterization of relapsed acute myeloid leukemia reveals novel putative therapeutic targets. Blood Advances. 5(3). 900–912. 31 indexed citations

7.

Skaftason, Aron, Ying Qu, Jessica Nordlund, et al.. (2021). Transcriptome sequencing of archived lymphoma specimens is feasible and clinically relevant using exome capture technology. Genes Chromosomes and Cancer. 61(1). 27–36. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact